SEARCH

SEARCH BY CITATION

References

  • 1
    Sela O, Shoenfeld Y: Cancer in autoimmune diseases. Semin Arthritis Rheum 18: 7787, 1988
  • 2
    Abu-Shakra M, Guillemin F, Lee P: Cancer in systemic sclerosis. Arthritis Rheum 36: 460464, 1993
  • 3
    Matteson EL, Hickey AR, McGuire L, Tilson HH, Urowitz MB, Members of the Rheumatoid Arthritis Azathioprine Registry Steering Committee: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 18: 809814, 1991
  • 4
    Black KA, Zilko PJ, Dawkins RL, Armstrong BK, Mastaglia GL: Cancer in connective tissue disease. Arthritis Rheum 25: 11301133, 1982
  • 5
    Lewis RB, Castor CW, Knisley RE, Bole GG: Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 19: 12561260, 1976
  • 6
    Canoso JJ, Cohen AS: Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 17: 383388, 1974
  • 7
    Bhalla R, Ajmani HS, Kim WW, Swedler WI, Lazarevic MB, Skosey JL: Systemic lupus erythematosus and Hodgkin's lymphoma. J Rheumatol 20: 13161320, 1993
  • 8
    Menon S, Snaith ML, Isenberg D: The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus 2: 177181, 1993
  • 9
    Petterson T, Pukkala E, Teppo L, Friman C: Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51: 437439, 1992
  • 10
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12721277, 1982
  • 11
    Statistics Canada: Cancer in Canada 1985, 1986. Health Rep 3 (Suppl 8): 1215, 1991
  • 12
    Breslow NE, Day NE: Rates and rate standardization. In, Statistical Methods in Cancer Research: The Design and Analysis of Cohort Studies. Vol. II. Lyons, International Agency for Research on Cancer, 1987
  • 13
    Gardner MJ, Altman DG: Statistics with Confidence. London, BMJ, 1989
  • 14
    Gladman DD, Urowitz MB: Systemic lupus erythematosus: clinical features. In, Primer on the Rheumatic Diseases. Tenth edition. Edited by HRSchumacherJr, JHKlippel, WJKoopman. Atlanta, Arthritis Foundation, 1993
  • 15
    Jordon E, Burnstein SL, Calabro JJ, Henderson ES: Multiple myeloma complicating the course of seronegative systemic lupus erythematosus. Arthritis Rheum 21: 260263, 1978
  • 16
    Deaton JG, Levin WF: Systemic lupus erythematosus and acute myeloblastic leukemia: report of their coexistence and a survey of possible associating features. Arch Intern Med 120: 345348, 1967
  • 17
    Elliot RW, Essenhigh DM, Morley AR: Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. BMJ 284: 11601161, 1982
  • 18
    Via CS, Handwerger BS: B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 5: 570574, 1993